Solid-in-Oil Nanodispersions for Transcutaneous Immunotherapy of Japanese Cedar Pollinosis
Open Access
- 6 March 2020
- journal article
- review article
- Published by MDPI AG in Pharmaceutics
- Vol. 12 (3), 240
- https://doi.org/10.3390/pharmaceutics12030240
Abstract
Japanese cedar pollinosis (JCP) is a common affliction caused by an allergic reaction to cedar pollen and is considered a disease of national importance in Japan. Antigen-specific immunotherapy (AIT) is the only available curative treatment for JCP. However, low compliance and persistence have been reported among patients subcutaneously or sublingually administered AIT comprising a conventional antigen derived from a pollen extract. To address these issues, many research studies have focused on developing a safer, simpler, and more effective AIT for JCP. Here, we review the novel antigens that have been developed for JCP AIT, discuss their different administration routes, and present the effects of anti-allergy treatment. Then, we describe a new form of AIT called transcutaneous immunotherapy (TCIT) and its solid-in-oil (S/O) nanodispersion formulation, which is a promising antigen delivery system. Finally, we discuss the applications of S/O nanodispersions for JCP TCIT. In this context, we predict that TCIT delivery by using a S/O nanodispersion loaded with novel antigens may offer an easier, safer, and more effective treatment option for JCP patients.Keywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology (Scientific Research (S) 16H06369)
This publication has 71 references indexed in Scilit:
- Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapyJournal of Allergy and Clinical Immunology, 2013
- Oral Immunotherapy for Pollen Allergy Using T-Cell Epitope-Containing Egg White Derived from Genetically Manipulated ChickensPLOS ONE, 2012
- Oral immunotherapy with transgenic rice seed containing destructed Japanese cedar pollen allergens, Cry j 1 and Cry j 2, against Japanese cedar pollinosisPlant Biotechnology Journal, 2012
- Effects of Various Saccharides on the Masking of Epitope Sites and Uptake in the Gut of Cedar Allergen Cry j 1−Saccharide Conjugates by a Naturally Occurring Maillard ReactionJournal of Agricultural and Food Chemistry, 2010
- Efficient induction of oral tolerance by fusing cholera toxin B subunit with allergen-specific T-cell epitopes accumulated in rice seedVaccine, 2008
- Oligomannose-coated liposomes as a therapeutic antigen-delivery and an adjuvant vehicle for induction of in vivo tumor immunityJournal of Controlled Release, 2008
- Isolation and characterization of native Cry j 3 from Japanese cedar (Cryptomeria japonica) pollenAllergy, 2007
- Effect of Cry-consensus Peptide, a Novel Recombinant Peptide for Immunotherapy of Japanese Cedar Pollinosis, on an Experimental Allergic Rhinitis Model in B10.S MiceAllergology International, 2007
- Barrier Function of the Skin: “La Raison d'Être” of the EpidermisJournal of Investigative Dermatology, 2003
- Inhibition of immunoglobulin E response to Japanese cedar pollen allergen (Cry j 1) in mice by DNA immunization: different outcomes dependent on the plasmid DNA inoculation methodImmunology, 2000